Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig B Thompson

Showing results (241-250 of 257) with videos related to

Pageof 26
Sort By:
Cancer Discovery|April 15, 2017
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic ModifiersJacob L Glass, Duane Hassane, Bas J Wouters, et al.
Nature|June 19, 2010
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Nature|November 26, 2009
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
The Journal of Clinical Investigation|January 23, 2018
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibitionAnna Sophia McKenney, Allison N Lau, Amritha Varshini Hanasoge Somasundara, et al.
The Journal of Clinical Investigation|September 18, 2018
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibitionAnna Sophia McKenney, Allison N Lau, Amritha Varshini Hanasoge Somasundara, et al.
Science Translational Medicine|November 25, 2016
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomasJill Bayliss, Piali Mukherjee, Chao Lu, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Mitochondrial ATP production promotes T cell differentiation and function by regulating chromatin accessibilityCharles Ng, Tak Shun Fung, Dayi Li, et al.
Cell|August 2, 2016
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic CancerIok In Christine Chio, Seyed Mehdi Jafarnejad, Mariano Ponz-Sarvise, et al.
Cancer Cell|December 7, 2010
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiationMaria E Figueroa, Omar Abdel-Wahab, Chao Lu, et al.
Nature Communications|July 9, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Jillian Phallen, Vilmos Adleff, et al.
Pageof 26

Showing results (241-250 of 257) with videos related to

Sort By:
Pageof 26
Cancer Discovery|April 15, 2017
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic ModifiersJacob L Glass, Duane Hassane, Bas J Wouters, et al.
Nature|June 19, 2010
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
Nature|November 26, 2009
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateLenny Dang, David W White, Stefan Gross, et al.
The Journal of Clinical Investigation|January 23, 2018
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibitionAnna Sophia McKenney, Allison N Lau, Amritha Varshini Hanasoge Somasundara, et al.
The Journal of Clinical Investigation|September 18, 2018
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibitionAnna Sophia McKenney, Allison N Lau, Amritha Varshini Hanasoge Somasundara, et al.
Science Translational Medicine|November 25, 2016
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomasJill Bayliss, Piali Mukherjee, Chao Lu, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Mitochondrial ATP production promotes T cell differentiation and function by regulating chromatin accessibilityCharles Ng, Tak Shun Fung, Dayi Li, et al.
Cell|August 2, 2016
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic CancerIok In Christine Chio, Seyed Mehdi Jafarnejad, Mariano Ponz-Sarvise, et al.
Cancer Cell|December 7, 2010
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiationMaria E Figueroa, Omar Abdel-Wahab, Chao Lu, et al.
Nature Communications|July 9, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Jillian Phallen, Vilmos Adleff, et al.
Pageof 26